1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Anders Kvanta: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen Aflibercept, Ranibizumab - Central Retinal Vein Occlusion | Phase 4 | Completed | Anders Kvanta | 40 | 2014-10-01 | 2020-12-04 |
Ranibizumab (1) · aflibercept (1)
Sweden (1)
Sofie Westman (1)